Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil J Freireich

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Cancer|October 7, 2018
Toward the potential cure of leukemias in the next decadeHagop M Kantarjian, Michael J Keating, Emil J Freireich
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
The leukemias: a half-century of discoveryEmil J Freireich, Peter H Wiernik, David P Steensma
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Retrospect of hematologic malignancies 2010Jorge E Cortés, Emil J Freireich, Hagop Kantarjian, et al.
Leukemia Research|January 17, 2002
Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosineDavid B Jendiroba, Jim Klostergaard, Afsaneh Keyhani, et al.
Leukemia Research|April 12, 2003
Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell linesMichael Pearlman, David Jendiroba, Lance Pagliaro, et al.
Leukemia & Lymphoma|January 25, 2014
Granulocyte concentrates from a single high-yield apheresis can be split to support multiple patientsFleur M Aung, Benjamin Lichtiger, Roland L Bassett, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2003
Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicityMichael Pearlman, David Jendiroba, Lance Pagliaro, et al.
Leukemia & Lymphoma|October 31, 2006
Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndromeAlberto J Montero, Zeev Estrov, Emil J Freireich, et al.
British Journal of Haematology|March 11, 2004
Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluationNada Orsolic, Francis J Giles, Henriette Gourdeau, et al.
Cancer|November 6, 2004
Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infectionsAmar Safdar, Hend A Hanna, Maha Boktour, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Cancer|October 7, 2018
Toward the potential cure of leukemias in the next decadeHagop M Kantarjian, Michael J Keating, Emil J Freireich
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
The leukemias: a half-century of discoveryEmil J Freireich, Peter H Wiernik, David P Steensma
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Retrospect of hematologic malignancies 2010Jorge E Cortés, Emil J Freireich, Hagop Kantarjian, et al.
Leukemia Research|January 17, 2002
Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosineDavid B Jendiroba, Jim Klostergaard, Afsaneh Keyhani, et al.
Leukemia Research|April 12, 2003
Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell linesMichael Pearlman, David Jendiroba, Lance Pagliaro, et al.
Leukemia & Lymphoma|January 25, 2014
Granulocyte concentrates from a single high-yield apheresis can be split to support multiple patientsFleur M Aung, Benjamin Lichtiger, Roland L Bassett, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2003
Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicityMichael Pearlman, David Jendiroba, Lance Pagliaro, et al.
Leukemia & Lymphoma|October 31, 2006
Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndromeAlberto J Montero, Zeev Estrov, Emil J Freireich, et al.
British Journal of Haematology|March 11, 2004
Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluationNada Orsolic, Francis J Giles, Henriette Gourdeau, et al.
Cancer|November 6, 2004
Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infectionsAmar Safdar, Hend A Hanna, Maha Boktour, et al.
Pageof 6